BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25174775)

  • 1. Initial LDCT appearance of incident lung cancers in the ITALUNG trial.
    Mascalchi M; Picozzi G; Falchini M; Vella A; Diciotti S; Carrozzi L; Pegna AL; Falaschi F
    Eur J Radiol; 2014 Nov; 83(11):2080-6. PubMed ID: 25174775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
    Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
    J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
    Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
    Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
    Crucitti P; Gallo IF; Santoro G; Mangiameli G
    Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses.
    Rampinelli C; Minotti M; Ancona E; Preda L; Bertolotti R; Summers P; Raimondi S; Bagnardi V; Bellomi M
    Eur Radiol; 2019 Jul; 29(7):3862-3870. PubMed ID: 31062136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.
    Pelosi G; Sonzogni A; Veronesi G; De Camilli E; Maisonneuve P; Spaggiari L; Manzotti M; Masullo M; Taliento G; Fumagalli C; Bellomi M; Travis WD; Kadivar M; Viale G
    Lung Cancer; 2008 Nov; 62(2):202-14. PubMed ID: 18450320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Early Lung Cancers Detected During Follow-Up of Idiopathic Interstitial Pneumonia: Serial CT Features.
    Oh SY; Kim MY; Kim JE; Kim SS; Park TS; Kim DS; Choi CM
    AJR Am J Roentgenol; 2015 Jun; 204(6):1190-6. PubMed ID: 26001227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density features of screened lung tumors in low-dose computed tomography.
    Shen WC; Liu JC; Shieh SH; Yang ST; Tseng GC; Hsu WH; Chen CY; Yu YH
    Acad Radiol; 2014 Jan; 21(1):41-51. PubMed ID: 24331263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
    Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
    Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans.
    Ritchie AJ; Sanghera C; Jacobs C; Zhang W; Mayo J; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Manos D; Seely JM; Burrowes P; Bhatia R; Atkar-Khattra S; van Ginneken B; Tammemagi M; Tsao MS; Lam S;
    J Thorac Oncol; 2016 May; 11(5):709-717. PubMed ID: 26994641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.
    Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M
    Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
    Hammer MM; Hunsaker AR
    AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk factors for lung cancer based on low-dose computed tomography screening].
    Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
    Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
    J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
    Roberts HC; Patsios DA; Paul NS; DePerrot M; Teel W; Bayanati H; Shepherd F; Johnston MR
    J Thorac Oncol; 2009 May; 4(5):620-8. PubMed ID: 19357540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.